Helix BioPharma Corp.
HBP.TO
Price:
$1.23
Market Cap:
$60.30M
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered ...[Read more]
Industry
Biotechnology
IPO Date
1996-08-13
Stock Exchange
TSX
Ticker
HBP.TO
PE Ratio
[-6.15]
ROE
[2.92%]
Current Ratio
[0.74]
Dividend Yield
[0%]
Enterprise Value
[59.59M]
Dividend History
The ROE as of October 2024 (TTM) for Helix BioPharma Corp. (HBP.TO) is 2.92%
According to Helix BioPharma Corp.’s latest financial reports and current stock price. The company's current ROE is 2.92%. This represents a change of 1.18% compared to the average of 227.62% of the last 4 quarters.
Helix BioPharma Corp. (HBP.TO) Historical ROE (quarterly & annually)
How has HBP.TO ROE performed in the past?
The mean historical ROE of Helix BioPharma Corp. over the last ten years is 5.85%. The current 2.92% ROE has changed -50.09% with respect to the historical average. Over the past ten years (40 quarters), HBP.TO's ROE was at its highest in in the July 2017 quarter at 7.33%. The ROE was at its lowest in in the October 2019 quarter at -4962.22%.
Average
5.85%
Median
50.83%
Minimum
-1905.96%
Maximum
59.25%
Helix BioPharma Corp. (HBP.TO) ROE by Quarter and Year
Discovering the peaks and valleys of Helix BioPharma Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 300.34%
Maximum Annual ROE = 59.25%
Minimum Annual Increase = -19463.39%
Minimum Annual ROE = -1905.96%
| Year | ROE | Change |
|---|---|---|
| 2023 | 745.26% | -139.10% |
| 2022 | -1905.96% | -435.61% |
| 2021 | 567.91% | -250.90% |
| 2020 | -376.36% | -264.05% |
| 2019 | 229.41% | -59.52% |
| 2018 | 566.73% | -99.04% |
| 2017 | 59.25% | -19463.39% |
| 2016 | -306.01% | 138.95% |
| 2015 | -128.07% | 0.25% |
| 2014 | -127.75% | 300.34% |
Helix BioPharma Corp. (HBP.TO) Average ROE
How has HBP.TO ROE performed in the past?
The current ROE of Helix BioPharma Corp. (HBP.TO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-197.59%
5-year avg
-147.95%
10-year avg
5.85%
Helix BioPharma Corp. (HBP.TO) ROE vs. Peers
How is HBP.TO’s ROE compared to its peers?
Helix BioPharma Corp.’s ROE is greater than Microbix Biosystems Inc. (18.87%), greater than Oncolytics Biotech Inc. (-114.55%), less than Spectral Medical Inc. (106.25%), greater than Theratechnologies Inc. (14.30%), greater than Resverlogix Corp. (12.20%),
| Company | ROE | Market cap |
|---|---|---|
| 18.87% | $45.45M | |
| -114.55% | $136.27M | |
| 106.25% | $175.35M | |
| 14.30% | $80.92M | |
| 12.20% | $16.66M |
Build a custom stock screener for Helix BioPharma Corp. (HBP.TO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Helix BioPharma Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Helix BioPharma Corp. (HBP.TO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Helix BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Helix BioPharma Corp.'s ROE?
How is the ROE calculated for Helix BioPharma Corp. (HBP.TO)?
What is the highest ROE for Helix BioPharma Corp. (HBP.TO)?
What is the 3-year average ROE for Helix BioPharma Corp. (HBP.TO)?
What is the 5-year average ROE for Helix BioPharma Corp. (HBP.TO)?
How does the current ROE for Helix BioPharma Corp. (HBP.TO) compare to its historical average?